By binding to transmembrane proteins (αβ integrins, CD44, EGF receptor/EGFR), MMP2 and MMP9 directly trigger intracellular signalling pathways that control tumour cell events [33] (Figure 1). The gene discussed is MMP2; the disease is neoplasm.